Sunbed businesses have been warned that their marketing must not minimise the cancer risks linked to tanning equipment, as regulators focus on how cosmetic and wellbeing services are presented to the public. The Advertising Standards Authority has made clear that firms promoting indoor tanning should avoid messaging that could leave customers with a false impression of safety.
The warning also covers claims that sunbeds can treat skin conditions or improve mental health. Such statements may appeal to consumers looking for relief from physical symptoms or low mood, but they must not be used in advertising if they are misleading. The regulator’s position places a clear boundary between promoting a tanning service and suggesting that it delivers medical or psychological benefits.
For companies in the sector, the issue is not limited to the wording of a single advert. Websites, social media posts, posters, booking pages and promotional offers can all shape how risk is understood. Marketing that presents tanning as low-risk, therapeutic or restorative may influence decisions by customers who do not have the clinical context needed to assess possible harm, particularly when references to skin cancer are softened or omitted.
The guidance carries wider significance for health advertising, where lifestyle services often overlap with claims about wellbeing. Businesses making objective health-related statements are expected to hold suitable evidence and to avoid implying that a commercial treatment can replace professional medical advice. In the case of sunbeds, the core concern is that promotional language should not obscure the known risks associated with exposure to ultraviolet radiation.
The regulator’s intervention is likely to prompt tanning salons and sunbed operators to review public-facing material, especially claims that link sessions with skin treatment, mood or general wellness. Clearer advertising does not prevent firms from describing the services they offer, but it requires them to do so without overstating benefits or diluting risk. For consumers, the message is equally direct: marketing should not be treated as medical reassurance.
